Showing results (161-170 of 274) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studySuresh S Ramalingam, Shivaani Kummar, John Sarantopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committeeLesley Seymour, S Percy Ivy, Daniel Sargent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
Pediatric Blood & Cancer|October 2, 2012
A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumorsMargaret E Macy, Tracey Duncan, James Whitlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)Holly A Massett, Grace Mishkin, Jeffrey A Moscow, et al.
Lancet (London, England)|August 14, 2022
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trialsDai Chihara, Ruitao Lin, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer InstituteDai Chihara, Erich P Huang, Shanda R Finnigan, et al.
Virchows Archiv : an International Journal of Pathology|April 14, 2006
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasisRiccardo Alessandro, Maria Antonietta Di Bella, Anna Maria Flugy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancerMahrukh M Hussain, Herbert Kotz, Lori Minasian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapyNilofer S Azad, Jeanny B Aragon-Ching, William L Dahut, et al.
Pageof 28